Mimickers of pituitary tumors.

M Citlalli Perez-Guzman, Gabriela Szuman, Abdulrahman Altwijri, Kevin Shek, Sylvia L Asa, Shereen Ezzat

Abstract read

In one paragraph

Article in Neuro-oncology advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M Citlalli Perez-GuzmanEndocrine Oncology Site Group, Princess Margaret Cancer Centre, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Gabriela SzumanEndocrine Oncology Site Group, Princess Margaret Cancer Centre, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Abdulrahman AltwijriEndocrine Oncology Site Group, Princess Margaret Cancer Centre, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Kevin ShekJoint Department of Medical Imaging, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Sylvia L AsaDepartment of Pathology, University Hospitals Cleveland and Case Western Reserve University, Cleveland, Ohio, USA.

Shereen EzzatEndocrine Oncology Site Group, Princess Margaret Cancer Centre, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enlargement of the pituitary gland and/or its surrounding structures on brain or sellar imaging is a frequent finding. The distinction between clinically relevant and incidental changes can be challenging. Furthermore, the assumption that sellar lesions reflect a true neoplasm must be rigorously questioned to avoid inappropriate treatment or unnecessary surveillance plans. Here we review wide-ranging conditions that can mimic primary pituitary tumors. We outline a suggested approach to rational decision-making.

Indexed as

hypophysitisimmunotherapypituitarypituitary neuroendocrine tumorssellar lesion

Identifiers

PMID40718387

DOI10.1093/noajnl/vdae085

PMCPMC12288132

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.